60 Degrees Pharmaceuticals, Inc. (SXTP) Stock Forecast
Data as of May 9, 2026Healthcare · Current price $1.55 (-1.86%)
Consensus Target
—
Upside
—
Analysts
3
Rating
Buy(2.00)
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
No analyst price targets available.
SXTP vs Sector & Market
| Metric | SXTP | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 3 | 8 | 19 |
| Target Upside | — | +1708.8% | +16.4% |
| P/E Ratio | -0.15 | 3.30 | 27.60 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $2M | $2M | $2M | 1 |
| 2027-12-31 | $3M | $3M | $3M | 1 |
| 2028-12-31 | $4M | $4M | $4M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-2.26 | $-2.21 | $-2.16 | 1 |
| 2027-12-31 | $-2.20 | $-2.16 | $-2.12 | 1 |
| 2028-12-31 | $-1.80 | $-1.76 | $-1.72 | 1 |
Frequently Asked Questions
What is the analyst consensus for SXTP?
The consensus among 3 analysts covering 60 Degrees Pharmaceuticals, Inc. (SXTP) is Buy with an average price target of N/A.
How many analysts cover SXTP?
3 analysts have issued ratings for 60 Degrees Pharmaceuticals, Inc. in the past 12 months.
Is SXTP a buy or sell right now?
Based on 3 analyst ratings, SXTP has a consensus rating of Buy (2.00/5) with a N/A upside to the consensus target of N/A.
What are the earnings estimates for SXTP?
Analysts estimate SXTP will report EPS of $-2.21 for the period ending 2026-12-31, with revenue estimated at $2M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.